Cerulean Pharma Closes Series D
Private Equity Hub • Dec 15, 2011Cerulean Pharma, a developer of nanopharmaceuticals, has closed a $15 million Series D financing with participation from new investor, CVF, an affiliate of Henry Crown and Company of Chicago, Illinois, as well as full participation from all other existing investors,… Full Story »

